MSN Laboratories: US appeals court reinstates pause on generic version of Novartis' Entresto
Novartis (NOVN.S), opens new tab won an order from a U.S. appeals court in Washington on Thursday temporarily blocking drugmaker MSN Pharmaceuticals from launching a generic version of Novartis' blockbuster heart-failure drug Entresto.
Read full article »
Managing Director
MSN Reddy
Msn Laboratories is a manufacturer of Active Pharmaceutical Ingredients and finished dosages in India.
Read more